Literature DB >> 10924311

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology.

W Haverkamp, G Breithardt, A J Camm, M J Janse, M R Rosen, C Antzelevitch, D Escande, M Franz, M Malik, A Moss, R Shah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10924311     DOI： 10.1053/euhj.2000.2249

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  84 in total

1.  More light on QT interval measurement.

Authors:  L Toivonen
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

2.  QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy.

Authors:  Adrián LLerena; Roland Berecz; Alfredo de la Rubia; Pedro Dorado
Journal:  Eur J Clin Pharmacol       Date:  2002-06       Impact factor: 2.953

3.  Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.

Authors:  Nkechi E Azie; Gregory Adams; Borje Darpo; Steven F Francom; Emery C Polasek; Joy M Wisser; Joseph C Fleishaker
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

4.  Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP).

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 5.  Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Authors:  Karine Titier; Pierre-Olivier Girodet; Hélène Verdoux; Mathieu Molimard; Bernard Bégaud; Wilhelm Haverkamp; Malcolm Lader; Nicholas Moore
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  Approach to wide complex tachycardias in patients without structural heart disease.

Authors:  L Eckardt; G Breithardt; P Kirchhof
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

7.  Reproducibility of computerized measurements of QT interval from multiple leads at rest and during exercise.

Authors:  Anna-Mari Hekkala; Heikki Väänänen; Heikki Swan; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-10       Impact factor: 1.468

Review 8.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

Review 9.  Genetics of acquired long QT syndrome.

Authors:  Dan M Roden; Prakash C Viswanathan
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 10.  A benefit-risk assessment of class III antiarrhythmic agents.

Authors:  Bente Brendorp; Oledyg Pedersen; Christian Torp-Pedersen; Naji Sahebzadah; Lars Køber
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.